Article
Comparative effective dose of ciprofol and propofol in suppressing cardiovascular responses to tracheal intubation: a single-center, double-blind, randomized, controlled clinical trial
2024-02-13
Abstract excerpt
<title>Abstract</title> <p>Ciprofol, a novel γ-aminobutyric acid receptor agonist, outperforms propofol with minimal cardiovascular effects, higher potency, reduced injection pain, and a broader safety margin. Despite these advantages, ciprofol's clinical research is still emerging. This study compares the median effective dose (ED50) and adverse reactions of ciprofol and propofol, in conjunction with sufentanil,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e556c54a-be4d-5c88-bf76-c23ead6d56f9
- DOI
- 10.21203/rs.3.rs-3904850/v1
